Clene Confident In Phase III Plans For CNM-Au8 In ALS With Six-Month Data

 
• By Alaric DeArment
  
Clene announced data on CMN-Au8 from the HEALEY ALS Platform Trial • Source: Shutterstock

More from Strategy

More from Business